| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |